This is an industry sponsored clinical trial using prostacyclin infusion to treat primary pulmonary hypertension(PPH), a uniformly fatal disease. Severely symptomatic but ambulatory patients with PPH will be studied to determine an appropriate intravenous dose, and the patients discharged to continue therapy at home.
Showing the most recent 10 out of 1232 publications